Highlights West Pharmaceutical Services, Inc. Xetra

Equities

WPS

US9553061055

Real-time Estimate Tradegate Other stock markets 04:06:43 2024-06-28 am EDT			5-day change	1st Jan Change
307.2 ^EUR	-10.32%		0.00%	0.00%

Jun. 13	West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing	MT
Jun. 04	Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy	May. 29	CI
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.	Apr. 25	CI
West Pharmaceutical's Q1 Adjusted Earnings, Net Sales Fall; 2024 Adjusted EPS Outlook Raised	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q1 Revenue $695.4M, vs. Street Est of $671.7M	Apr. 25	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q1 EPS $1.56, vs. Street Est of $1.29	Apr. 25	MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Reaffirms Earnings Guidance for the Full Year 2024	Apr. 25	CI
West Pharmaceutical Services, Inc. Announces Third Quarter 2024 Dividend, Payable on August 7, 2024	Apr. 25	CI
Ex-dividend day	Apr. 22	FA
Ex-dividend day	Apr. 22	FA
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
Accenture: acquisition of Australian company The Lumery	Mar. 04	CF
West Pharmaceutical Services Maintains Quarterly Dividend at $0.20 per Share; Payable May 1 to Holders of Record on April 24	Feb. 20	MT
West Pharmaceutical Services, Inc. Announces Second Quarter 2024 Dividend, Payable on May 1, 2024	Feb. 20	CI
Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.	Feb. 15	CI
West Pharmaceutical Services Q4 Adjusted Earnings, Net Sales Increase	Feb. 15	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Posts Q4 Revenue $732M, vs. Street Est of $739.5M	Feb. 15	MT
Earnings Flash (WST) WEST PHARMACEUTICAL SERVICES Reports Q4 EPS $1.83, vs. Street Est of $1.78	Feb. 15	MT
West Pharmaceutical Services, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights West Pharmaceutical Services, Inc. Xetra

Equities

WPS

US9553061055

Highlights

Filters